Scholars Central

Conference abstractPublished 18 Oct 2017

Comparative anti-inflammatory activities of Sulfasalazine alone and combination with Scutellariae radix and Bupleuri radix mixture on DSS-induced colitis mice model

Authors: Su Ji Kim, Mi-Rae Shin, Kyeong Jo Kim, Soo Hyun Kim, Bu-Il Seo, Seong-Soo Roh

Daegu Haany University, Republic of Korea

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Sulfasalazine commonly used in Ulcerative Colitis (UC), potentially has various adverse effects after high dosage and long term intake. The present study aimed to investigate the comparative evaluation of pharmacological efficacy between Sulfasalazine alone and combination with herbal medicine on Dextran Sodium Sulfate (DSS)-induced UC in mice. To induce UC, Balb/c mice were treated 5% DSS water solution for 7 days. Animals were divided into five groups (n=9); Group-1: Normal group; Group-2: DSS control group; Group-3: DSS+sulfasalazine (30 mg/kg); Group-4: DSS+sulfasalazine (60 mg/kg); Group-5: DSS+sulfasalazine (30 mg/kg)+Scutellariae radix and Bupleuri radix mixture (30 mg/kg) (SSB). The anti-oxidant, inflammatory and apoptotic protein levels were determined using western blotting. DSS-treated mice developed symptoms similar to those of human UC, such as severe bloody diarrhea and weight loss. SSB supplementation, as well as sulfasalazine suppressed colonic length shortening and mucosal inflammatory injury. In addition, significantly reduced the expression of pro-inflammatory signaling molecules through suppression of both Mitogen-Activated Protein Kinases (MAPK) and Nuclear Factor-kappa B (NF-Ã?ºB) signaling pathways and prevented the apoptosis of colon, moreover, SSB significantly up-regulated antioxidant enzymes including SOD and catalase. This is the first report that Scutellariae radix and Bupleuri radix mixture combined with sulfasalazine protects against experimental UC via the inhibition of both inflammation and apoptosis, very similar to the standard-of-care sulfasalazine. We conclude that SSB can provide better treatments for UC than sulfasalazine alone or may be useful as an alternative treatment strategy for UC, without evidence of side effects.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Medicinal & Aromatic Plants.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal & Aromatic Plants
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Su Ji Kim”
  • BylineArticles whose byline prints “Mi-Rae Shin”
  • BylineArticles whose byline prints “Kyeong Jo Kim”
  • BylineArticles whose byline prints “Soo Hyun Kim”
  • BylineArticles whose byline prints “Bu-Il Seo”
  • BylineArticles whose byline prints “Seong-Soo Roh”